{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:42:34Z","timestamp":1793364154757,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001439"],"award-info":[{"award-number":["UL1TR001439"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD047891"],"award-info":[{"award-number":["U54HD047891"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD047905"],"award-info":[{"award-number":["U54HD047905"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD085601"],"award-info":[{"award-number":["U54HD085601"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajog.2021.05.018","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T03:59:41Z","timestamp":1621828781000},"page":"666.e1-666.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-469X","authenticated-orcid":false,"given":"Maged M.","family":"Costantine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Wisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Caritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Stika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Rytting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Snodgrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Nanovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Patrikeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minaz","family":"Cattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Mesches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Alfred L.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"DeAngeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.05.018_bib1","first-page":"1","article-title":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bpobgyn.2011.04.002","article-title":"Pre-eclampsia in low and middle income countries","volume":"25","author":"Firoz","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib3","article-title":"The role of statins in the prevention of preeclampsia","author":"Smith","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2021.05.018_bib5","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","author":"Staff","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib6","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","author":"Rana","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(94)92639-5","article-title":"Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein","volume":"343","author":"Branch","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.05.018_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2021.05.018_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0378(03)00044-5","article-title":"Trophoblast deportation and the maternal inflammatory response in pre-eclampsia","volume":"59","author":"Sargent","year":"2003","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2021.05.018_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2021.05.018_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.05.018_bib12","article-title":"Prevention of preeclampsia with aspirin","author":"Rolnik","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2004.01.038","article-title":"Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?","volume":"175","author":"Rodie","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajog.2021.05.018_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2021.05.018_bib16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.05.018_bib17","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","author":"Tong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajog.2021.05.018_bib19","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.05.018_bib20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/BST0371237","article-title":"Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?","volume":"37","author":"Ahmed","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ajog.2021.05.018_bib21","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.freeradbiomed.2004.09.009","article-title":"The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells","volume":"37","author":"Grosser","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajog.2021.05.018_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA Reductase Inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2021.05.018_bib23","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","author":"Endres","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2021.05.018_bib24","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib26","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.05.018_bib27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/bmc.3581","article-title":"Quantitative determination of pravastatin and its metabolite 3\u03b1-hydroxy pravastatin in plasma and urine of pregnant patients by LC-MS\/MS","volume":"30","author":"Zhang","year":"2016","journal-title":"Biomed Chromatogr"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2021.05.018_bib28","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/BF03216282","article-title":"Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase","volume":"40","author":"Pan","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2021.05.018_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2125.1990.tb03626.x","article-title":"Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects","volume":"29","author":"Singhvi","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2021.05.018_bib30","unstructured":"United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: bioanalytical method validation. 2013. Available at: https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. Accessed January 16, 2021."},{"key":"10.1016\/j.ajog.2021.05.018_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2125.1993.tb04227.x","article-title":"Steady state serum concentrations of pravastatin and digoxin when given in combination","volume":"36","author":"Triscari","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2021.05.018_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.30386","article-title":"Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins","volume":"131","author":"Edison","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ajog.2021.05.018_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2021.05.018_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA Reductase Inhibitors: effects on fetal and neonatal outcomes","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2021.05.018_bib35","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.05.018_bib36","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth defects: a case-series approach","volume":"146A","author":"Petersen","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ajog.2021.05.018_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.05.018_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: a systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.ajog.2021.05.018_bib39","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.0000017634.00171.24","article-title":"Safety and tolerability of pravastatin in long-term clinical trials: prospective pravastatin Pooling (PPP) Project","volume":"105","author":"Pfeffer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2021.05.018_bib40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ajcn\/82.6.1155","article-title":"Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation","volume":"82","author":"Woollett","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2021.05.018_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(81)90065-2","article-title":"The effects of dietary cholesterol upon the hypercholesterolemia of pregnancy","volume":"30","author":"McMurry","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2021.05.018_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/ajcn\/31.7.1131","article-title":"The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico","volume":"31","author":"Connor","year":"1978","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2021.05.018_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.earlhumdev.2014.07.014","article-title":"Auditory neural myelination is associated with early childhood language development in premature infants","volume":"90","author":"Amin","year":"2014","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2021.05.018_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00003088-200039060-00002","article-title":"Clinical pharmacokinetics of\u00a0pravastatin: mechanisms of pharmacokinetic events","volume":"39","author":"Hatanaka","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2021.05.018_bib45","doi-asserted-by":"crossref","first-page":"373.e1","DOI":"10.1016\/j.ajog.2013.05.038","article-title":"Transplacental transfer and distribution of pravastatin","volume":"209","author":"Nanovskaya","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.placenta.2013.05.002","article-title":"The transfer of pravastatin in the dually perfused human placenta","volume":"34","author":"Zarek","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.05.018_bib47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bcp.2018.09.012","article-title":"Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin","volume":"156","author":"Afrouzian","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2021.05.018_bib48","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2021.05.018_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.05.018_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.05.018_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/14767058.2015.1129779","article-title":"Pravastatin for the prevention of adverse pregnancy outcome: preeclampsia and more?","volume":"30","author":"Chaiworapongsa","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.05.018_bib52","article-title":"Evaluating the effect of pravastatin in early-onset fetal growth restriction: a nonrandomized and historically controlled pilot study","author":"Mendoza","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2021.05.018_bib53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821005846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821005846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:35:14Z","timestamp":1757590514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821005846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0002937821005846"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.05.018","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}